» Articles » PMID: 11060501

Neutralizing Antibody Provided Protection Against Enterovirus Type 71 Lethal Challenge in Neonatal Mice

Overview
Journal J Biomed Sci
Publisher Biomed Central
Specialty Biology
Date 2000 Nov 4
PMID 11060501
Citations 50
Authors
Affiliations
Soon will be listed here.
Abstract

Experimental infection with enterovirus type 71 (EV71) induced death in neonatal mice in an age- and dose-dependent manner. The mortality rate was 100% following intraperitoneal inoculation 1-day-old ICR mice and this gradually decreased as the age at the time of inoculation increased (60% in 3-day-old mice and no deaths occurred in mice older than 6 days of age). A lethal dose greater than 10(8) PFU was necessary. Lethargy, failure to gain weight, rear limb tremors and paralysis were observed in the infected mice before death. EV71 was isolated from various tissues of the dead mice. Using a reverse transcription polymerase chain reaction technique with a specific primer pair, a 332-bp product was detected in the tissues that produced a culture positive for EV71. Protection against EV71 challenge in neonatal mice was demonstrated following passive transfer of serum from actively immunized adult mice 1 day after inoculation with the virus. Pups from hyperimmune dams were resistant to EV71 challenge. Additionally, maternal immunization with a formalin-inactivated whole-virus vaccine prolonged the survival of pups after EV71 lethal challenge.

Citing Articles

A nucleoside-modified mRNA vaccine prevents enterovirus A71 infection in mouse model.

Chi F, Zhang X, Zhang D, Zhu A, Zhuang Z, Zhang Z Front Immunol. 2025; 16:1535758.

PMID: 40013142 PMC: 11861539. DOI: 10.3389/fimmu.2025.1535758.


Evaluation of the cross-neutralization activities elicited by Coxsackievirus A10 vaccine strains.

Huo Y, Yang J, Liu P, Cui B, Wang C, Liu S Hum Vaccin Immunother. 2021; 17(12):5334-5347.

PMID: 34756160 PMC: 8903991. DOI: 10.1080/21645515.2021.1978792.


A practical method for evaluating the efficacy of EVA-71 vaccine using a hSCARB2 knock-in mouse model.

Wu Y, Qu Z, Xiong R, Yang Y, Liu S, Nie J Emerg Microbes Infect. 2021; 10(1):1180-1190.

PMID: 34044752 PMC: 8205003. DOI: 10.1080/22221751.2021.1934558.


Neutralizing Ljungan virus antibodies in children with newly diagnosed type 1 diabetes.

Lundstig A, McDonald S, Maziarz M, Weldon W, Vaziri-Sani F, Lernmark A J Gen Virol. 2021; 102(5).

PMID: 34020728 PMC: 8969827. DOI: 10.1099/jgv.0.001602.


Efficacy of a coxsackievirus A6 vaccine candidate in an actively immunized mouse model.

Qian S, Wei Z, Jin W, Wu J, Zhou Y, Meng S Emerg Microbes Infect. 2021; 10(1):763-773.

PMID: 33739899 PMC: 8079124. DOI: 10.1080/22221751.2021.1906755.